Published in Arch Intern Med on February 11, 2002
Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults. AIDS (2008) 1.85
Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing age. AIDS (2012) 1.57
Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C. Pediatr Infect Dis J (2010) 1.31
Pregnancy outcomes in women exposed to efavirenz and nevirapine: an appraisal of the IeDEA West Africa and ANRS Databases, Abidjan, Côte d'Ivoire. J Acquir Immune Defic Syndr (2011) 1.10
Pharmacokinetic interactions between the hormonal emergency contraception, levonorgestrel (Plan B), and Efavirenz. Infect Dis Obstet Gynecol (2012) 0.98
Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum. J Acquir Immune Defic Syndr (2012) 0.95
Evaluation and treatment of the human immunodeficiency virus-1-exposed infant. Paediatr Child Health (2004) 0.93
Quantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the USA. HIV Med (2011) 0.89
Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants. JAMA Pediatr (2015) 0.87
Treatment switches during pregnancy among HIV-positive women on antiretroviral therapy at conception. AIDS (2011) 0.82
Tuberculosis and the obstetrician-gynecologist: a global perspective. Rev Obstet Gynecol (2013) 0.82
Efavirenz use during pregnancy and for women of child-bearing potential. AIDS Res Ther (2006) 0.81
Antiretroviral therapy, pregnancy, and birth defects: a discussion on the updated data. HIV AIDS (Auckl) (2013) 0.80
First trimester exposure to antiretroviral therapy and risk of birth defects. Pediatr Infect Dis J (2014) 0.80
The treatment of patients with HIV. Dtsch Arztebl Int (2010) 0.78
Impact of gender on response to highly active antiretroviral therapy in HIV-1 infected patients: a nationwide population-based cohort study. BMC Infect Dis (2012) 0.78
Effect of Host Genetic Variation on the Pharmacokinetics and Clinical Response of Non-nucleoside Reverse Transcriptase Inhibitors. Futur HIV Ther (2008) 0.77
Disclosing in utero HIV/ARV exposure to the HIV-exposed uninfected adolescent: is it necessary? J Int AIDS Soc (2016) 0.75
Birth defects in a cohort of infants born to HIV-infected women in Spain, 2000-2009. BMC Infect Dis (2014) 0.75
Pharmacologic and nonpharmacologic options for the management of HIV infection during pregnancy. HIV AIDS (Auckl) (2009) 0.75
Hemangiomas and other congenital malformations in infants exposed to antiretroviral therapy in utero. JAMA (2004) 1.38
Uterine prolapse in pregnancy. Gynecol Obstet Invest (2005) 1.34
Syphilis Infection during pregnancy: fetal risks and clinical management. Infect Dis Obstet Gynecol (2012) 1.25
Radiation effects on development. Birth Defects Res C Embryo Today (2007) 1.02
Fetal exposure to isotretinoin-an international problem. Reprod Toxicol (2007) 0.97
Longitudinal changes of adiponectin, carbohydrate and lipid metabolism in pregnant women at high risk for gestational diabetes. Gynecol Endocrinol (2010) 0.93
Latanoprost exposure in pregnancy. Am J Ophthalmol (2004) 0.91
Homocysteine induces trophoblast cell death with apoptotic features. Biol Reprod (2003) 0.88
Paternal exposure to ribavirin: pregnancy and neonatal outcome. Antivir Ther (2003) 0.86
Risk of drug-induced congenital defects. Eur J Obstet Gynecol Reprod Biol (2004) 0.84
Early first-trimester sibutramine exposure : pregnancy outcome and neonatal follow-up. Drug Saf (2006) 0.83
Sexuality, pre-conception counseling and urological management of pregnancy for young women with spina bifida. Eur J Obstet Gynecol Reprod Biol (2012) 0.82
Cancer in pregnancy: results of a series of 32 patients. Anticancer Res (2006) 0.80
The intracoelomic route: a new approach for in utero human cord blood stem cell transplantation. Fetal Diagn Ther (2003) 0.80
A novel route of transplantation of human cord blood stem cells in preimmune fetal sheep: the intracelomic cavity. Stem Cells (2003) 0.79
'Two-step' head-to-body delivery activates foetal gluconeogenesis. Acta Paediatr (2013) 0.79
Failure of the emergency contraceptive levonorgestrel and the risk of adverse effects in pregnancy and on fetal development: an observational cohort study. Fertil Steril (2005) 0.78
Future learning abilities of late preterm infants. Am J Obstet Gynecol (2012) 0.76
First case of post-conception Verteporfin exposure: pregnancy and neonatal outcome. Acta Ophthalmol Scand (2004) 0.76
Relationship between the neonatal white blood cell count and histologic chorioamnionitis in preterm newborns. J Matern Fetal Neonatal Med (2012) 0.76
Head-to-body delivery by "two-step" approach: effect on cord blood hematocrit. J Matern Fetal Neonatal Med (2013) 0.76
Common occurrence of anaemia at the end of pregnancy following exposure to zidovudine-free regimens. J Infect (2011) 0.76
Body image and breastfeeding practices in obese mothers. Eat Weight Disord (2013) 0.76
Prenatal drug exposure and teratological risk: one-year experience of an Italian Teratology Information Service. Med Sci Monit (2008) 0.76
Multidetector CT appearance of the pelvis after cesarean delivery: normal and abnormal acute findings. Diagn Interv Radiol (2016) 0.75
A survey of central association members about the definition, management, and complications of shoulder dystocia. Obstet Gynecol (2012) 0.75
First-trimester itraconazole exposure and pregnancy outcome: a prospective cohort study of women contacting teratology information services in Italy. Drug Saf (2009) 0.75
Effect of HCV infection on glucose metabolism in pregnant women with HIV receiving HAART. HIV Clin Trials (2010) 0.75
Coping strategies in low-risk pregnant women: the influence of low and late fertility. J Matern Fetal Neonatal Med (2013) 0.75
Rubella susceptibility profile in pregnant women with HIV. Clin Infect Dis (2011) 0.75
Prostaglandin: cervical ripening in hypertensive pregnancies. Acta Obstet Gynecol Scand (2003) 0.75
The need for restricted prescription of retinoic acid derivative isotretinoin to prevent retinoid teratogenicity. Prev Med (2007) 0.75
The morbidly adherent placenta: when and what association of signs can improve MRI diagnosis? Our experience. Diagn Interv Radiol (2017) 0.75